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Objectives: Cholera, a key social development indicator remains an acute global 
public health threat (Dunkle ,2011 Penguele, 2011). Ghana has seen recurrent 
epidemics in recent years, posing health system challenge. This study aimed to 
describe, identify the cause and socio-economic factors associated with 2012 chol-
era outbreak in Osu-Klottey district for policy recommendations. MethOds: We 
conducted descriptive and unmatched case-control study. Cholera case-patient was 
person with acute diarrhea with/without vomiting in the district from 1st March to 
30th November 2012. We interviewed participants on socio-economic, household 
hygiene, food, water exposures with structured questionnaires and mapped their 
residence geospatially. Data was managed and analyzed in Stata 11/SE. Results: 
Index case, 23 year old male Nima resident reported at Ridge hospital on 9th March 
2012 after eating street-vendors “Waakye”. The outbreak caused by Vibrio cholerae 
O1 El-Tor biotype, serotype ogawa had two peaks with total of 494 cases with 3 
mortalities (Attack rate; 383/100,000 populations, 0.61% fatality). Age ranged 2- 83; 
mean and median 31+/-14.4 and 27 years respectively. Majority of cases were from 
Ayawaso and Osu-Klottey. Prompt case management, infection prevention prac-
tices, contact tracing, sensitization campaigns and proper cadaver disposal were 
instituted. Monthly income, daily-food-expenditure ranged 10–500 USD and 0.50–25 
USD respectively among participants. Logistic regression analysis (95% confidence 
interval) showed age below 18 years (AOR= 7.69, CI 1.38-42.73), education below ter-
tiary (AOR= 2.96, CI 1.16-7.54), exclusive household toilet facility (AOR= 0.289, CI 0.12-
0.70), cold/warm food (AOR= 3.11, CI 1.34-7.23), home food (AOR= 0.083, CI 0.39-0.18) 
and community pipe-borne water (AOR= 2.15, CI 1.04-4.44) were associated. Hand 
washing with soap-water, slum residence, and daily-food-expenditure below 5.0USD 
and alcohol ingestion showed significant association only with bivariate analy-
sis. cOnclusiOns: Sanitary reforms and infrastructural development is crucial to 
combat recurrence of cholera epidemic, however multi-sectorial approach including 
oral cholera vaccine for the under-18 year olds would make significant impact.
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aSSESSmEnt oF diabEtES riSk For dEtEction oF tyPE 2 diabEtES 
mEllituS in younG adultS
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bharati vidyapeeth Medical College, Pune 43, India
Objectives: According to World Health Organisation , a disease of the middle-aged 
and elderly, type 2 diabetes has recently escalated in all age groups and is now being 
identified in younger and younger age groups, including adolescents and children, 
especially in high-risk population. This underscores the need for mass awareness 
and screening programmes to detect diabetes at an early stage and early age.So 
the purpose of the study is to find risk of type 2 diabetes mellitus mellitus in young 
adults at an early age. MethOds: 405 students of Bharati Vidyapeeth Deemed 
University Medical College were screened for family history of diabetes, exercise 
status and waist circumference. After scoring them they were categorised into mild, 
moderate and high risk group. Results: We have assessed 405 students which 
includes 258 girls and 147 boys students till now. It was observed that 4% ,71% & 25 
% students in high, Moderate & Low risk group respectively for developing type 2 
D.M. Mean abdominal obesity in high risk students was 101.95± 5.76 as compared to 
79.17 ± 11.08 in moderate and low risk students(p< 0.0001). Family history of diabetes 
in either or both parents was present in 21% students. 55% students were having 
sedentary lifestyle. cOnclusiOns: This underscores the urgent need for further 
investigations to detect diabetes at an early stage and to overcome the disease 
burden of diabetes in future. This is the simplest way to screen large population. 
Also in students who are having score more than 50. To prevent and to postpone 
the risk of type 2 diabetes mellitus, health education programme, exercise and diet 
planning should be recommended for these students
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Objectives: As part of a series of systematic reviews of end-of-life care interven-
tions we sought to evaluate the determinants of place of death in an end-of-life 
population. MethOds: A systematic review of the literature was undertaken in 
order to identify randomized controlled trials, observational studies, or prior sys-
tematic reviews published between January 1, 2004, and September 24, 2013 evalu-
ating the determinants of death in different locations (home, nursing home, and 
inpatient hospice). Determinants related to the illness, living arrangements, support 
to caregiver, hospital bed availability, home or palliative care, patient and fam-
ily preference were evaluated. The adjusted odds ratios (ORs) and 95% confidence 
intervals (CIs) from multivariate analyses were extracted. Meta-analyses were per-
formed when appropriate. Results: Four systematic reviews and 32 observational 
studies were included, mostly retrospective cohort studies based on administra-
tive databases. Three studies (9.4%) were from Canada, 6 (18.8%) from the United 
States, and 9 (28.1%) from Europe. Eight (25%) studies included patients receiving 
multidisciplinary home care, 11 (34.4%) were restricted to cancer patients. Factors 
increasing the likelihood of home vs. hospital death included multidisciplinary 
home care team (OR: 8.40 [95% CI: 4.67–15.09], 1 study), and home visits by family 
physicians in patients receiving home care (OR: 2.26 [1.35–3.78], 3 studies, I2= 22%). 
Admission to a hospital having a multidisciplinary palliative support team or hos-
pice unit decreased the likelihood of home death (OR: 0.54 [0.33–0.89], 2 studies, 
Objectives: Uganda has a high population growth rate (3.2%) and a high fertil-
ity rate (6.2 children per woman), primarily due to the low prevalence of mod-
ern contraceptive use. We examined factors associated with contraceptive use 
and the choice of contraceptive methods by Ugandan women of reproductive 
age. MethOds: We obtained demographic, socioeconomic and contraceptive use 
data on women aged 15-49 years from the Uganda Demographic Health Survey 
(UDHS) 2011. We performed descriptive analyses to examine the frequency of use 
and contraceptive choice. We fit exploratory binary and multinomial logit models 
to examine demographic and socioeconomic factors associated with contraceptive 
use and choice of contraceptive. Results: Our analysis included 8647 women 
with data on contraceptive use. 22.87% reported current use of contraceptives. The 
most commonly used methods were injections (44.25%) and condoms (14.72%). 
In the logit model, higher odds of contraceptive use was associated with higher 
age (OR 1.38 95% CI: 1.29, 1.49), being in a higher wealth quintile (OR 1.27, 95% CI: 
1.21, 1.34), higher level of education (OR 1.28, 95% CI: 1.20, 1.37) and employment 
(OR 1.46, 95% CI: 1.28, 1.65). Women who desired more than 8 children had lower 
odds (OR 0.58, 95% CI: 0.46, 0.73) of using contraceptives. The reference outcome 
group in the multinomial logit model was “not using any contraception”. Age, employ-
ment status, level of education, wealth quintile, region of country, number of 
children and desire for more children as important determinants of choice of 
contraceptive. However the effects differed according to the choice of contracep-
tive. cOnclusiOns: Our study shows that the prevalence of contraceptive use 
is very low in Uganda and identifies some determinants of contraceptive use 
and method choice. There is need to focus reproductive health research towards 
identifying contraceptive characteristics that may influence choice in order to 
design more holistic contraceptive policy.
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Objectives: In the UK, dengue fever is a travel associated viral infection which 
is endemic in over 110 countries and is transmitted through a mosquito vector. 
Infection may develop into severe dengue which can lead to death. There is currently 
no licensed immunisation to protect against infection, although vaccines are in 
development. In 2009 the Health Protection Agency in England commenced monitor-
ing the prevalence, so there is no longitudinal data on UK rates. This study describes 
the rates of infections by year and the population characteristics of those acquiring 
dengue fever recorded in a primary care database. MethOds: The THIN primary 
care database contains 12 million patients with 3.8 million active patients in 2012. 
An observational, retrospective study was conducted from 1/1/2002 – 31/12/2012. 
All patients with a coded diagnosis of dengue fever in this period were included. 
The variables were: age, gender, ethnicity, social deprivation score and month of 
diagnosis. Results: The annual rates of dengue fever pmp in THIN from 2002 – 2013 
were 4.0, 3.7, 7.9, 5.3, 3.3, 6.5, 5.0, 1.9, 7.4, 5.8, 5.8 respectively. The 4 years of HPA data 
from 2009 to 2012 were very similar to THIN rates (2.9, 7.1, 3.9, 5.9). 58% of patients 
were males. The percentage by age bands 0 – 19, 20-39, 40 – 59, 60+ were 8%, 48%, 
30%, 14% respectively. cOnclusiOns: Between 2002 – 2013 there was year to year 
variability in dengue infection rates, although the UK travellers have seen no rise in 
rates of dengue fever during this period. The 4 years of HPA reported rates are very 
similar to THIN rates. Infection was reported more frequently in males, and almost 
half of infections occurred in the 20–39 year age group. This may just reflect their 
greater propensity to travel to affected destinations.
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Objectives: To identify incidence and direct medical cost of patients diagnosed 
with all-cause pneumonia and acute otitis media through EMR database and 
health information database (HID) in Minhang district, Shanghai. MethOds: 
Cases were definite by ICD-10 code and identified for a two-year period, from 
Jan 1st of 2011 to Dec 31th of 2012 from EMR database. Relevant medical cost was 
collected from HID, ancillary cost data – such as costs of medical procedures, 
medications, and facility utilization was estimated through survey. These data 
were combined used unique patients identification number. Patients were classi-
fied into age groups and incidence and medical costs data were reported based on 
the age groups. Results: The highest incidence of inpatient all-cause pneumonia 
was 795 episodes per 100,000 person-year in children under 2 years, it decreases 
as population ages but reverse the trend with patients age 50 and above. The 
second high incidence appeared in senior people aged 65 and above (249 per 
100,000 person year). There was similar trend for outpatient all- cause pneumonia 
and Acute Otitis Media. The cost analysis indicated that the medical direct cost 
per case increases and population ages. The highest median cost (95% range) for 
hospitalization all-cause pneumonia was RMB 7,851.6 (1,903.7-47,607.4) Yuan for 
age 65 and older, and the lowest cost per case appeared in children under 2 years. 
Similar trend was also observed for the outpatient all-cause pneumonia costs and 
AOM costs. cOnclusiOns: Outpatient all-cause pneumonia is a major public 
burden in current Chinese treatment pattern of pneumococcal relevant diseases, 
especially in children under 5 and senior people age 65 and above. In adults and 
senior people, the medical direct cost of all-cause pneumonia reaches 7,851 RMB 
per episode which accounts for 9.51% of 2011 Shanghai per person GDP and 22.32% 
of 2011China per person GDP.
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CI1.05-1.89; p= 0.024). MI were slightly less likely to schedule DFE vs. UC (38% vs. 
42%, RR0.90; CI0.66-1.22; p= NSS) and attend DFE (32% vs. 36%; RR0.90; CI 0.63-1.28; 
p= NSS). The total cost of TI was $603.98 or $5.03/participant and the cost/follow-up 
DFE was $26.05. Sensitivity analyses revealed that the cost/follow-up can be greatly 
reduced but remains additional vs. UC ($2.76 if $0.25/call, $11.13 if $1/call; $22.29 
if $2/call). cOnclusiOns: Personal phone assistance in scheduling DFE follow-
up assistance is more effective but also more costly. Follow-up research has been 
initiated to determine whether automated phone reminders can achieve similar 
effectiveness at a lower cost.
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Objectives: Compare health care resource utilization and costs of Cushing disease 
(CD) cases to CD-free controls. MethOds: A retrospective matched-cohort study 
design was used to analyze the administrative claims of commercial health plan 
enrollees with evidence of CD from 2007-2011. CD cases were matched 1:3 to CD-free 
controls by age, sex, region, and index year. CD cases were identified using a Cushing 
syndrome diagnosis code (ICD-9: 255.0) and codes for a CD-related diagnosis or 
procedure (e.g., pituitary neoplasm or hypophysectomy). CD cases were observed for 
≥ 6 months after their first CD-related claim. Controls were observed starting in the 
same index year. Per-patient-per-month (PPPM) counts and costs of all-cause health 
care resource utilization were compared descriptively. Costs were CPI-adjusted to 
2011 dollars and included health plan- and patient-paid amounts. Results: Among 
the 885 selected CD cases and 2,655 matched controls, the mean (SD) age was 42 
(14) years and 75% were female. Median follow-up was 2.4 years for cases and 1.5 
years for controls. Compared to controls, cases had a higher proportion of inpa-
tient admissions (50% vs. 11%; p< 0.001), emergency department visits (61% vs. 20%; 
p< 0.001), and outpatient visits (95% vs. 63%; p< 0.001). Average monthly counts of 
utilization for cases were 2-4 times higher than controls: ambulatory visits (2.5 vs. 
0.9; p< 0.001), ED visits (0.1 vs. 0.04; p< 0.001), and inpatient admissions (0.03 vs. 0.01; 
p< 0.001). Average PPPM total all-cause costs were also higher for cases than controls 
($3,224 vs. $486; p< 0.001), and were largely driven by medical costs ($2,790 vs. $382; 
p< 0.001). Average PPPM pharmacy costs were 4 times higher for cases than controls 
($434 vs. $104; p< 0.001). cOnclusiOns: In this study, high health care resource 
utilization and costs were identified for CD cases compared to CD-free controls. In 
addition to CD treatment costs, differences included the costs of diagnosing and 
treating the multiple comorbidities often observed in CD patients.
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Objectives: In Ukraine COPD is significant medical and socio-economic prob-
lem. The aim of this study was to assess and compare the 2013 annual exacerba-
tion-related direct costs in COPD stages subpopulations. MethOds: Costs were 
assessed with State Budget perspective. Inpatient costs included service costs and 
costs for diagnostic procedures. Outpatient costs included physician visits and 
spirometry costs. Epidemiological and cost data were obtained from the appro-
priate 2012-2020 model. Data about the proportions of I-IV COPD were obtained 
from Ukrainian study: I, II, III and IV was 20%, 44%, 29% and 7%, respectively. Data 
about annual exacerbations and hospitalizations rates were obtained from GOLD 
2013: I: no data; II:0.7-0.9 and 0.11-0.2; III:1.1-1.3 and 0.25-0.3; VI:1.2-2.0 and 0.4-0.54, 
respectively. We made an assumption that the annual number of exacerbation led 
to outpatient visits was the difference between total exacerbations rate and hos-
pitalization rate (2 outpatient visits per exacerbation). Costs were considered in 
minimal and maximal exacerbation rates scenarios and were calculated per sub-
population and per patient. 11% inflation rate, 17.6% social-tax and 17% VAT were 
applied. Exchange rate 1USD= 7.99UAH on 30.12.2013. Results: In 2013 number 
of COPD patients in Ukraine was 581,598. Number of patients with I, II, III and IV 
stages could amount 116,320; 255,903; 168,663 and 40,712, respectively. Minimal-
maximal annual inpatient costs in II, III and IV COPD subpopulations could amount 
$6,310,192.66-$11,473,077.56 ($25.00-$45.00 per patient), $9,452,232.30-$11,342,678.76 
($56.04-$67.25 per patient) and $3,650,538.95-$4,928,227.58 ($90.00-$121.00 per 
patient), respectively. Minimal-maximal annual outpatient costs in II, III and IV 
subpopulations could amount $859,721.71-$1,355,712.42 ($3.36-$5.30 per patient), 
$1,253,374.56-$1,645,054.12 ($7.43-$9.75 per patient) and $889,441.63-$2,156,222.13 
($21.85-$52.96 per patient), respectively. cOnclusiOns: Total direct costs were 
largest in COPD III patients, but per-patient direct costs were largest in COPD IV. So, 
in case of COPD-related costs assessment the stratification of patients by airflow 
limitation and exacerbations rates should be taken in account.
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EStimatinG tHE coSt oF trEatinG HyPoGlycEmc EvEntS in tHE mExican 
Public HEaltH carE SyStEm
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Objectives: Estimate the cost of treating hypoglycemic events in patients with 
type 2 diabetes mellitus (DM2), in the Mexican public health care system using 
data from two databases and to compare these costs according to hypoglycemic 
event severity. MethOds: A Cost Analysis was developed to estimate the economic 
impact of treating hypoglycemic events. Definition of hypoglycemia was according 
with the published by Jonsson and colleagues1: Mild, Moderate and Severe. The use 
of resources was validated with an expert panel of specialists from the public health 
system. Only direct costs were used in this analysis. Estimates were obtained from 
I2= 18%]. Having an end-of-life, hospice, or palliative care facility in the nursing home 
increased the likelihood of dying in a nursing home vs. hospital (OR 7.79 [2.22–27.31], 
4 studies, I2= 98%). cOnclusiOns: Availability of services influences the site of 
death. For patients preferring death at home, the presence of a multidisciplinary 
home care team is one of the factors that can support home death.
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Objectives: This study was conducted to evaluate the appropriate use of medi-
cines among the hospitalized patients with renal impairment. MethOds: Study 
Design:The study was a retrospective study in which medication charts (prescription 
and laboratory reports) of patients were used to evaluate appropriate use of medi-
cines. Setting: Data was collected from nephrology departments of selected hospitals 
of Gujarat, Bahawalpur and Lahore. Main outcome measure: Percentage of prescrip-
tions containing contraindicated drugs, percentage of prescriptions containing 
drugs prescribed without adjusting their doses, percentage of prescriptions contain-
ing drug-drug interactions and percentage of drugs prescribed without specifying 
any dose. Results: About 500 prescriptions of patients (male and female) with 
moderate and severe renal impairment were collected and evaluated. According 
to this study, contraindicated drugs were observed in 30.8% prescriptions, drugs 
prescribed without dose adjustment were found in 51% prescriptions, drug-drug 
interactions were observed in 63.6% prescriptions and drugs prescribed without 
any specific dosage regimen in 4.8% prescriptions. At least one drug interaction was 
found in each prescription (median = 1, inter quartile range = 1-6). cOnclusiOns: 
This study showed the negligence of health care providers especially physicians 
and nephrologists. The study provided evidence that either physicians do not take 
notice of patient’s renal function while prescribing or are incompetent enough to 
take such measures. Interventions are required to improve the prescribing quality 
and prescribers’ behaviors that will ultimately improve the quality of care.
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Objectives: The Post-Licensure Rapid Immunization Safety Monitoring (PRISM) pro-
gram was created in response to the need of the U.S. Food and Drug Administration 
(FDA) to monitor the safety of H1N1influenza vaccine. Later PRISM was incorporated 
into the FDA’s Mini-Sentinel Initiative to evaluate the safety of other vaccines. We 
describe the distributed data structure used in this system. MethOds: PRISM uses 
a distributed data method whereby claims data processed through 3 health insur-
ance companies, “Data Partners,” are organized into a standardized common data 
model (CDM). Data in this standard format are refreshed on a quarterly basis and 
stored by the Data Partners. Mini-Sentinel programs are run on these data to extract 
aggregate data for analysis. The data in the CDM are augmented by linking to eight 
state and city Immunization Information Systems (IIS) to obtain additional vaccine 
exposure data. Results: The CDM includes 110 million lives, 2.6 billion dispensing, 
and 3.1 billion health care encounters from 2004-2012 from the three Data Partners, 
representing three major health insurance companies. The vaccine data from the 
state IIS improve the completeness of vaccine information for individuals. In 2012, 
unrestricted (including states even if they did not contribute data) analysis showed 
that IIS contributed an additional 5-9% of vaccine administration data. In the chart 
validation assessing the risk of intussusception following rotavirus vaccination, 
it was identified that 46% (124/267) of cases identified by the electronic algorithm 
were true intussusception cases. Reports on one vaccine safety assessment has 
been completed. cOnclusiOns: Vaccines are an essential component to maintain 
public health. The benefits of the PRISM system include the large pooled population, 
enhanced ability to capture data from alternative sources, and ability to evaluate the 
potential risks of rare adverse events; the distributed data model ensures patient 
confidentiality. Validation by chart review adds precision to the evaluations.
HEaltH SErvicES – cost Studies
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Objectives: To compare effectiveness and costs of personal reminder approaches 
(mailed vs. phone) to improve dilated fundus examination (DFE) follow-up adher-
ence in patients with diabetes. MethOds: In a prospective trial, 356 diabetics due 
for DFE were randomly assigned to usual care (UC; reference case), mailed interven-
tion (MI), or telephone intervention (TI). UC (n= 119) received a standard form letter. 
MI (n= 117) received a personalized letter encouraging scheduling of eye examina-
tion with an educational brochure about diabetic eye disease. TI (n= 120) received 
personal calls (up to 3 attempts) to schedule a follow-up with standard form letter. 
The primary outcome was DFE within 90 days of suggested return. Costs ($US 2013) 
included time costs (staff time in preparing letters, conducting calls, and documen-
tation converted to dollars using wages + benefit costs), phone charges, supplies, 
and postage. Since TI dominated MI, univariate sensitivity analysis examined the 
impact of reducing phone costs. Results: Participants were mostly female (66%) 
and African-American (70%) with a mean age of 61 years. TI were more likely to 
schedule DFE (65% vs. 42%; RR1.54; CI1.20-1.96; p< 0.001) vs. UC. DFE within 90 days 
of suggested return in TI was also significantly higher than UC (51% vs. 36%, RR1.41; 
